Cas no 797-58-0 (18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)-)
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17α)- is a synthetic steroid derivative with a modified pregnane skeleton, featuring a 13-ethyl substitution and a 17α-hydroxy group. This structural configuration enhances its stability and bioavailability, making it suitable for specialized pharmaceutical or research applications. The compound's unsaturated 4-en-3-one moiety is characteristic of many bioactive steroids, suggesting potential interactions with steroid receptors or enzymes. Its precise pharmacological profile depends on further functionalization or context of use. The 13-ethyl group may influence metabolic resistance, while the 17α-hydroxy group could modulate solubility or binding affinity. This compound serves as a versatile intermediate for steroid synthesis or mechanistic studies.
797-58-0 structure
Product Name:18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)-
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- Chemical and Physical Properties
Names and Identifiers
-
- 18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)-
- Norbolethone
- α-Norbolethone
- Aids125925
- Aids-125925
- Norbalethone
- Gon-4-en-3-one,17.alpha.-diethyl-17-hydroxy-
- D05204
- O60979L83F
- 797-58-0
- dl-13,17a-Diethyl-17-hydroxygon-4-en-3-one
- NORBOLETHONE [MI]
- WLN: L E5 B666 OV MUTJ E2 FQ F2
- Norbolhetone
- (+/-)-17a-Ethyl-18-homo-19-nortestosterone
- Norboletonum [INN-Latin]
- (+/-)-13-ethyl-17-hydroxy-18,19-Dinor-17a-pregn-4-en-3-one
- Genabol
- AKOS030253215
- NS00067955
- (17.ALPHA.)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-3-ONE
- NSC89791
- 1235-15-0
- Norboletone
- 13,17.ALPHA.-DIETHYL-17-HYDROXYGON-4-EN-3-ONE
- HY-U00108
- 13.BETA.,17.ALPHA.-DIETHYL-17.BETA.-HYDROXYGON-4-EN-3-ONE
- Norboletona [INN-Spanish]
- 18,19-DINORPREGN-4-EN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-, (+/-)-
- Norboletone, (+)-
- (1S,2R,10R,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one
- CHEMBL2105134
- Norbolethone (1.0mg/ml in Acetonitrile)
- (+/-)-13,17a-Diethyl-17b-hydroxygon-4-en-3-one
- MLS002694957
- Norbolethone D-form [MI]
- alpha-Norbolethone
- 18, 13-ethyl-17-hydroxy-
- CS-7144
- 18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-, (+-)-
- 18,19-Dinor-17alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-
- (17a)-(+/-)-13-ethyl-17-hydroxy-18,19-Dinorpregn-4-en-3-one
- dl-17b-Hydroxy-13b,17a-diethylgon-4-en-3-one
- 18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-
- 18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-
- FTBJKONNNSKOLX-XUDSTZEESA-N
- UNII-U3BZU2241A
- Norboletonum
- Norbolethone (USAN)
- 13-Ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-4-en-3-one
- DL-13,17a-Diethyl-17b-hydroxygon-4-en-3-one
- SCHEMBL548124
- (+/-)-13b,17a-Diethyl-17b-hydroxygon-4-en-3-one
- 18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17alpha)-, (+-)-
- Wy 3475
- 18,19-Dinor-17.alpha.-pregn-4-en-3-one, 13-ethyl-17-hydroxy-
- D-Norbolethone
- (+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-3-one
- Norbolethone [USAN]
- U3BZU2241A
- (.+-.)-13-Ethyl-17-hydroxy-18,19-dinor-17.alpha.-pregn-4-en-3-one
- DTXSID50154027
- (+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha -pregn-4-en-3-one
- DL-Norbolethone
- NSC-89791
- 18, 13-ethyl-17-hydroxy-, (17.alpha.)-
- WY-3475
- UNII-O60979L83F
- 13-ethyl-17-hydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one
- 18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-
- 13beta,17alpha-Diethyl-17beta-hydroxygon-4-en-3-one
- Norboletona
- NSC 89791
- Q410981
- NORBOLETONE [MART.]
- dl-13-beta,17-alpha-Diethyl-17-beta-hydroxygon-4-en-3-one
- Norbolethone [USAN:INN]
- 13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-3-one
- DTXSID801015371
- Norboletone [INN]
- (8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
- 3-Ethyl-17-hydroxy-18,19-dinor-pregn-4-en-3-one
- Norbolethone, (+)-
- 13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-3-ONE
-
- Inchi: 1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
- InChI Key: FTBJKONNNSKOLX-XUDSTZEESA-N
- SMILES: O[C@@]1(CC)CC[C@H]2[C@@H]3CCC4=CC(CC[C@@H]4[C@H]3CC[C@@]21CC)=O
Computed Properties
- Exact Mass: 316.24000
- Monoisotopic Mass: 316.24
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 23
- Rotatable Bond Count: 2
- Complexity: 536
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 6
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 37.3A^2
- XLogP3: 3.8
Experimental Properties
- Density: 1.0382 (rough estimate)
- Boiling Point: 395.89°C (rough estimate)
- Flash Point: 195.6oC
- Refractive Index: 1.5344 (estimate)
- PSA: 37.30000
- LogP: 4.65940
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | N62440-5mg |
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- |
797-58-0 | 99% | 5mg |
¥3252.0 | 2022-04-27 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | N62440-10mg |
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- |
797-58-0 | 99% | 10mg |
¥5522.0 | 2022-04-27 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | N62440-1mg |
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- |
797-58-0 | 99% | 1mg |
¥1622.0 | 2022-04-27 |
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)- Related Literature
-
Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
-
Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
-
Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
-
Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
Related Categories
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Gluco/mineralocorticoids, progestogins and derivatives
- Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Steroids and steroid derivatives Pregnane steroids Gluco/mineralocorticoids, progestogins and derivatives
Recommended suppliers
Shenzhen GeneSeqTools Bioscience & Technology Co. Ltd.
Gold Member
CN Supplier
Reagent
Hebei Liye chemical Co.,Ltd
Gold Member
CN Supplier
Bulk
上海帛亦醫(yī)藥科技有限公司
Gold Member
CN Supplier
Reagent
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
CN Supplier
Bulk
Shandong Jing Kun Chemical Co.,Ltd.
Gold Member
CN Supplier
Bulk